EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors

Kensuke Nakagawara, Makoto Ando iD, Tanakorn Srirat, Setsuko Mise-Omata, Taeko Hayakawa, Minako Ito, Koichi Fukunaga, Akihiko Yoshimura iD

Journal for ImmunoTherapy of Cancer · 2024-08 · 12 (8) · e008665

DOI: 10.1136/jitc-2023-008665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 16.08.2024. Verfasst von Kensuke Nakagawara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan yoshimura@keio.jp k.nakagawara@keio.jp. Hauptthemen laut MEDLINE: Mitochondria, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Science Foundation, Chemo-Sero-Therapeutic Research Institute, the Yasuda Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antitumor effect of chimeric antigen receptor (CAR)-T cells against solid tumors is limited due to various factors, such as low infiltration rate, poor expansion capacity, and exhaustion of T cells within the tumor. NR4A transcription factors have been shown to play important roles in T-cell exhaustion in mice. However, the precise contribution of each NR4a factor to human T-cell differentiation remains to be clarified.

Methods

In this study, we deleted NR4A family factors, NR4A1 , NR4A2, and NR4A3, in human CAR-T cells recognizing human epidermal growth factor receptor type 2 (HER2) by using the CRISPR/Cas9 system. We induced T-cell exhaustion in these cells in vitro through repeated co-culturing of CAR-T cells with Her2 + A549 lung adenocarcinoma cells and evaluated cell surface markers such as memory and exhaustion phenotypes, proliferative capacity, cytokine production and metabolic activity. We validated the antitumor toxicity of NR4A1/2/3 triple knockout (TKO) CAR-T cells in vivo by transferring CAR-T cells into A549 tumor-bearing immunodeficient mice.

Results

Human NR4A-TKO CAR-T cells were resistant against exhaustion induced by repeated antigen stimulation in vitro, and maintained higher tumor-killing activity both in vitro and in vivo compared with control CAR-T cells. A comparison of the effectiveness of NR4A single, double, and TKOs demonstrated that triple KO was the most effective in avoiding exhaustion. Furthermore, a strong enhancement of antitumor effects by NR4A TKO was also observed in T cells from various donors including aged persons. Mechanistically, NR4A TKO CAR-T cells showed enhanced mitochondrial oxidative phosphorylation, therefore could persist for longer periods within the tumors.

Conclusions

NR4A factors regulate CAR-T cell persistence and stemness through mitochondrial gene expression, therefore NR4A is a highly promising target for the generation of superior CAR-T cells against solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansAnimalsMiceNuclear Receptor Subfamily 4, Group A, Member 1Nuclear Receptor Subfamily 4, Group A, Member 2Receptors, Thyroid HormoneNeoplasmsT-LymphocytesXenograft Model Antitumor AssaysFemaleDNA-Binding ProteinsReceptors, Steroid

Stichwörter der Autor:innen

Adoptive cell therapy - ACTChimeric antigen receptor - CARLung CancerSolid tumorStem cell

Substanzen

Receptors, Chimeric AntigenNuclear Receptor Subfamily 4, Group A, Member 1Nuclear Receptor Subfamily 4, Group A, Member 2NR4A2 protein, humanNR4A1 protein, humanNR4A3 protein, humanReceptors, Thyroid HormoneDNA-Binding ProteinsReceptors, Steroid

Autor:innen und Institutionen

  • Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan yoshimura@keio.jp k.nakagawara@keio.jp.
  • Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
  • Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Division of Allergy and Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
  • Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan yoshimura@keio.jp k.nakagawara@keio.jp.

ORCID-Profile: Makoto Ando, Akihiko Yoshimura

Förderung

  • Takeda Science Foundation
  • Chemo-Sero-Therapeutic Research Institute
  • the Yasuda Medical Foundation
  • the Princess Takamatsu Cancer Research Fund
  • Uehara Memorial Foundation
  • the Japan Agency for Medical Research and Development (AMED)-CREST
  • AMED-Moonshot
  • Keio Gijuku Academic Developmental Funds

Zitieren

APA

Nakagawara, K., Ando, M., Srirat, T., Mise-Omata, S., Hayakawa, T., Ito, M., Fukunaga, K., & Yoshimura, A. (2024). NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors. Journal for ImmunoTherapy of Cancer, 12(8), e008665. https://doi.org/10.1136/jitc-2023-008665

Vancouver

Nakagawara K, Ando M, Srirat T, Mise-Omata S, Hayakawa T, Ito M, et al. NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors. Journal for ImmunoTherapy of Cancer. 2024;12(8):e008665. doi:10.1136/jitc-2023-008665

BibTeX
@article{Nakagawara2024,
  author = {Nakagawara, Kensuke and Ando, Makoto and Srirat, Tanakorn and Mise-Omata, Setsuko and Hayakawa, Taeko and Ito, Minako and Fukunaga, Koichi and Yoshimura, Akihiko},
  title = {NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {e008665},
  doi = {10.1136/jitc-2023-008665}
}
Kostenlos starten →